NovoCure Ltd — Director's Dealing 2020

Sep 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2020-09-14

Reporting Person: LEUNG GABRIEL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-14	Ordinary Shares	M	10000	$7.48	Acquired	82045	Direct
2020-09-14	Ordinary Shares	S	10000	$95	Disposed	72045	Direct
2020-09-15	Ordinary Shares	M	2173	$7.48	Acquired	74218	Direct
2020-09-15	Ordinary Shares	S	2173	$100	Disposed	72045	Direct
2020-09-15	Ordinary Shares	M	7392	$7.48	Acquired	79437	Direct
2020-09-15	Ordinary Shares	S	7392	$100	Disposed	72045	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-14	Options to Buy Ordinary Shares	$7.48	M	10000	Disposed	2024-02-25	Ordinary Shares (10000.0)	Direct
2020-09-15	Options to Buy Ordinary Shares	$7.48	M	2173	Disposed	2024-02-25	Ordinary Shares (2173.0)	Direct
2020-09-15	Options to Buy Ordinary Shares	$7.48	M	7392	Disposed	2024-02-25	Ordinary Shares (7392.0)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen.

F2: Fully vested as of the date hereof.